CRISPR-mediated Gene Editing Using a cGMP-Compliant Non-viral Cell Engineering: From iPSC Disease Modeling to Clinically-Meaningful Correction of Monogenic Disease Mutations in Patient Cells

2020-07-10T15:47:11+00:00May 12th, 2020|Comments Off on CRISPR-mediated Gene Editing Using a cGMP-Compliant Non-viral Cell Engineering: From iPSC Disease Modeling to Clinically-Meaningful Correction of Monogenic Disease Mutations in Patient Cells

Advancing Next Generation Cell and Gene Therapies to the Clinic Using Non-viral, Scalable Engineering and Genome Modification of Human Primary Cells, Stem Cells and iPSCs.

2020-07-07T17:05:49+00:00May 12th, 2020|0 Comments

Extracellular nanovesicles for packaging of CRISPRCas9 protein and sgRNA to induce therapeutic exon skipping

2020-11-02T22:18:19+00:00March 13th, 2020|Comments Off on Extracellular nanovesicles for packaging of CRISPRCas9 protein and sgRNA to induce therapeutic exon skipping
Go to Top